Literature DB >> 3039382

Metabolism of bradykinin and angiotensin I by human basilar artery and rabbit aorta.

E T Whalley.   

Abstract

The role of angiotensin converting enzyme in the metabolism of bradykinin and angiotensin I by in vitro human basilar artery and rabbit aorta was studied. On both human basilar artery and rabbit aorta concentration-effects curves to angiotensin I were significantly attenuated by captopril at a concentration which had no effect on bradykinin responses on both tissues. The metabolism of bradykinin and angiotensin I was studied using high performance liquid chromatography. Both peptides were broken down by human basilar artery and rabbit aorta in a similar fashion. The breakdown of angiotensin I but not bradykinin was significantly attenuated by captopril. 1,10-phenanthroline did attenuate breakdown of bradykinin but this was found not to be significant compared with controls. The results confirm that angiotensin converting enzyme is present in both these tissues and is important for the conversion of angiotensin I to angiotensin II. It appears that other peptidases are important in the breakdown of kinins by these tissues and should be taken into account when investigating the mechanism of action of such peptides on these vascular preparations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039382     DOI: 10.1007/BF00169123

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

1.  The regeneration of aortic endothelium.

Authors:  J C POOLE; A G SANDERS; H W FLOREY
Journal:  J Pathol Bacteriol       Date:  1958-01

2.  Kininases and vascular responses to kinins.

Authors:  C Babiuk; F Marceau; S St-Pierre; D Regoli
Journal:  Eur J Pharmacol       Date:  1982-02-26       Impact factor: 4.432

3.  Effects of kininase II inhibitors on the vasomotor response to bradykinin of feline intracranial and extracranial arteries in vitro and in situ.

Authors:  M Wahl; A R Young; L Edvinsson; F Wagner
Journal:  J Cereb Blood Flow Metab       Date:  1983-09       Impact factor: 6.200

Review 4.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

5.  Design of potent and specific inhibitors of carboxypeptidases A and B.

Authors:  M A Ondetti; M E Condon; J Reid; E F Sabo; H S Cheung; D W Cushman
Journal:  Biochemistry       Date:  1979-04-17       Impact factor: 3.162

6.  Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence.

Authors:  U S Ryan; J W Ryan; C Whitaker; A Chiu
Journal:  Tissue Cell       Date:  1976       Impact factor: 2.466

7.  Mechanisms of brain inactivation of centrally-acting thyrotrophin-releasing hormone (TRH) analogues: a high-performance liquid chromatography study.

Authors:  E C Griffiths; J R McDermott; A I Smith
Journal:  Regul Pept       Date:  1982-12

8.  Angiotensin-converting enzyme, bradykinin, angiotensin, and cerebral vessel reactivity.

Authors:  E T Whalley; M Wahl; C A Sampaio
Journal:  Hypertension       Date:  1983 Nov-Dec       Impact factor: 10.190

9.  Actions of bradykinin on isolated cerebral and peripheral arteries.

Authors:  N Toda
Journal:  Am J Physiol       Date:  1977-03

10.  Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N.

Authors:  I A Sheikh; A P Kaplan
Journal:  Biochem Pharmacol       Date:  1986-06-15       Impact factor: 5.858

View more
  3 in total

1.  Effects of angiotensin I and angiotensin II in blood vessels: greater influence of converting enzyme activity in the rabbit basilar artery.

Authors:  A Zerrouk; M Auguet; S Delaflotte; P E Chabrier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

2.  Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.

Authors:  F Lembeck; T Griesbacher; M Eckhardt
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

3.  Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation.

Authors:  T Griesbacher; F Lembeck; A Saria
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.